Abstract
The focus of this paper is on three major questions: (1) what is the theoretical rationale for the strategic group concept?; (2) does strategic group membership have performance implications?; and (3) are strategic groups and membership in strategic groups stable characteristics of industries? A statistical procedure is proposed to longitudinally identify strategic groups. The empirical setting is the U.S. pharmaceutical industry over the period 1963–82. While performance differences are found in terms of market share, profitability differences between groups are not observed. Neither are differences found in terms of risk and risk-adjusted performance. These results are attributed to the existence of performance variation within each strategic group. A dynamic model of competitive repositioning is proposed which helps integrate the findings from the study.
Keywords
Profitability indexIndustrial organizationProfit impact of marketing strategyPharmaceutical industryStrategic managementGroup (periodic table)MarketingBusinessCompetitive advantageStrategic planningMarket shareOperations managementEconomicsStrategic financial managementFinanceBiotechnology
Affiliated Institutions
Related Publications
Growth strategies for service firms
Abstract Two characteristics of services—intangibility of the offering and simultaneity of production and consumption—have important implications for strategic planning. Four of...
Strategic Factor Markets: Expectations, Luck, and Business Strategy
Much of the current thinking about competitive strategy focuses on ways that firms can create imperfectly competitive product markets in order to obtain greater than normal econ...
Generic knowledge strategies in the U.S. pharmaceutical industry
Abstract The purpose of this study is to identify groups of firms with similar generic knowledge strategies, determine how these strategies change over time, and compare profit ...
Does Governance Matter? <i>Keiretsu</i> Alliances and Asset Specificity as Sources of Japanese Competitive Advantage
This empirical study suggests that Japanese competitive advantage in complex-product industries is at least partly due to differences in value chain governance and interfirm ass...
The cornerstones of competitive advantage: A resource‐based view
Abstract This paper elucidates the underlying economics of the resource‐based view of competitive advantage and integrates existing perspectives into a parsimonious model of res...
Publication Info
- Year
- 1987
- Type
- article
- Volume
- 33
- Issue
- 9
- Pages
- 1102-1124
- Citations
- 532
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
532
OpenAlex
Cite This
Karel Cool,
Dan Schendel
(1987).
Strategic Group Formation and Performance: The Case of the U.S. Pharmaceutical Industry, 1963–1982.
Management Science
, 33
(9)
, 1102-1124.
https://doi.org/10.1287/mnsc.33.9.1102
Identifiers
- DOI
- 10.1287/mnsc.33.9.1102